PHARMACOLOGICAL EVALUATION OF ANXIOLYTICS AND NICOTINE FOR ANXIETY-RELATED BEHAVIORS AND NEURONAL ACTIVITIES
Toshitaka Nabeshima(Fujita Health University), Masaya Hasegawa(Fujita Health University), Kazuo Kunisawa(Fujita Health University), Akihiro Mouri(Fujita Health University)
Cited by 0
Related Papers
Chronic unpredictable mild stress-induced behavioral changes are coupled with dopaminergic hyperfunction and serotonergic hypofunction in mouse models of depression
|Behavioural Brain Research|2019|90
Heat-sterilized Bifidobacterium breve prevents depression-like behavior and interleukin-1β expression in mice exposed to chronic social defeat stress
|Brain Behavior and Immunity|2021|80
High salt induces cognitive impairment via the interaction of the angiotensin II‐AT<sub>1</sub> and prostaglandin E2‐EP<sub>1</sub> systems
|British Journal of Pharmacology|2023|15
Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine‐3‐monooxygenase with microglial decline
|British Journal of Pharmacology|2024|15